WO2002043649A8 - Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof - Google Patents

Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof

Info

Publication number
WO2002043649A8
WO2002043649A8 PCT/IL2001/001088 IL0101088W WO0243649A8 WO 2002043649 A8 WO2002043649 A8 WO 2002043649A8 IL 0101088 W IL0101088 W IL 0101088W WO 0243649 A8 WO0243649 A8 WO 0243649A8
Authority
WO
WIPO (PCT)
Prior art keywords
probiotic
therapeutic
industrial applications
compositions
preparation
Prior art date
Application number
PCT/IL2001/001088
Other languages
French (fr)
Other versions
WO2002043649A3 (en
WO2002043649A2 (en
Inventor
Mark Olshenitsky
Genadi Buchman
Original Assignee
Bio Balance Corp
Mark Olshenitsky
Genadi Buchman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/725,846 external-priority patent/US6500423B2/en
Priority to IL15621301A priority Critical patent/IL156213A0/en
Priority to CA002430292A priority patent/CA2430292A1/en
Priority to NZ526748A priority patent/NZ526748A/en
Priority to JP2002545628A priority patent/JP4410992B2/en
Priority to BR0116178-4A priority patent/BR0116178A/en
Priority to EP01998302A priority patent/EP1343370A4/en
Priority to MXPA03004851A priority patent/MXPA03004851A/en
Application filed by Bio Balance Corp, Mark Olshenitsky, Genadi Buchman filed Critical Bio Balance Corp
Priority to KR10-2003-7007337A priority patent/KR20030082549A/en
Priority to AU2002221004A priority patent/AU2002221004B2/en
Priority to US10/432,346 priority patent/US7504251B2/en
Priority to AU2100402A priority patent/AU2100402A/en
Publication of WO2002043649A2 publication Critical patent/WO2002043649A2/en
Publication of WO2002043649A3 publication Critical patent/WO2002043649A3/en
Publication of WO2002043649A8 publication Critical patent/WO2002043649A8/en
Priority to AU2007201690A priority patent/AU2007201690A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84—Flavour masking or reducing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)

Abstract

The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.
PCT/IL2001/001088 1999-06-03 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof WO2002043649A2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU2100402A AU2100402A (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
MXPA03004851A MXPA03004851A (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof.
NZ526748A NZ526748A (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
JP2002545628A JP4410992B2 (en) 2000-11-30 2001-11-27 Bacterial strains, treated plant extracts, compositions containing them, methods for their preparation, and their therapeutic and industrial applications
KR10-2003-7007337A KR20030082549A (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
EP01998302A EP1343370A4 (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
CA002430292A CA2430292A1 (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
IL15621301A IL156213A0 (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
BR0116178-4A BR0116178A (en) 2000-11-30 2001-11-27 Bacterial strain, probiotic composition comprising a bacterial strain, formulation comprising at least a volatile fraction of a plant extract, food additive, process for preparing a volatile fraction of a plant, process for preparing a therapeutic formulation, process for growing a bacterial strain, process for manufacturing a probiotic composition, process for preparing a probiotic composition, process for preparing a composition including viable microorganisms, microorganism dispenser, method of biocontrolling an organism, method for eliminating an oil pollution, method recovery of organic fumes, food product and initial preparation method for a fermentation process
AU2002221004A AU2002221004B2 (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
US10/432,346 US7504251B2 (en) 1999-06-03 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
AU2007201690A AU2007201690A1 (en) 2000-06-01 2007-04-17 Preparation of Compositions Comprising Bacterial Strains and Volatile Plant Extracts and Therapeutic and Industrial Applications Thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/725,846 US6500423B2 (en) 1999-06-03 2000-11-30 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
US09/725,846 2000-11-30

Publications (3)

Publication Number Publication Date
WO2002043649A2 WO2002043649A2 (en) 2002-06-06
WO2002043649A3 WO2002043649A3 (en) 2002-08-29
WO2002043649A8 true WO2002043649A8 (en) 2004-04-29

Family

ID=24916190

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/001088 WO2002043649A2 (en) 1999-06-03 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof

Country Status (14)

Country Link
EP (1) EP1343370A4 (en)
JP (1) JP4410992B2 (en)
KR (1) KR20030082549A (en)
CN (1) CN1294253C (en)
AU (2) AU2100402A (en)
BR (1) BR0116178A (en)
CA (1) CA2430292A1 (en)
IL (1) IL156213A0 (en)
MX (1) MXPA03004851A (en)
NZ (1) NZ526748A (en)
PL (1) PL366363A1 (en)
RU (1) RU2281326C2 (en)
WO (1) WO2002043649A2 (en)
ZA (1) ZA200304747B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
IL152127A0 (en) 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
RU2006108554A (en) * 2003-08-18 2007-09-27 Дзе Байо Бэлэнс Корпорейшн (Us) SUSTAINABLE LIQUID PROBIOTIC COMPOSITION, ITS PRODUCTION AND APPLICATIONS
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
US20090252708A1 (en) * 2006-05-18 2009-10-08 Biobalance Llc Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
RU2453320C2 (en) * 2008-08-05 2012-06-20 Виктор Владимирович Чалов Oral composition containing nonpathogenic microorganisms showing ability to normalise intestinal microflora (versions)
KR101127171B1 (en) * 2009-07-24 2012-03-20 (주)애드바이오텍 Composition of feed additives for ducks comprising egg yolk containing IgY against pathogen to induce acute and chronic infection disease
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
RU2458527C1 (en) * 2010-12-30 2012-08-20 Общество с ограниченной ответственностью "БИОТРОФ" Method for production of preparation for feeding farm animals and birds and method for preparation of fodder based on it
PT2875121T (en) 2012-07-20 2018-03-14 Prevtec Microbia Inc Non-pathogenic f18 e. coli strain and use thereof
JP6452607B2 (en) 2012-09-25 2019-01-16 アキロン セイエレ エセ．エレ． Probiotic composition and prebiotic composition
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
SG10201704035TA (en) * 2012-11-23 2017-06-29 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
KR102222273B1 (en) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 Compositions and methods
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102379658B1 (en) 2013-11-25 2022-03-28 세레스 테라퓨틱스, 인코포레이티드 Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RU2660355C2 (en) * 2016-04-01 2018-07-05 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Antibacterial pharmaceutical composition for oral use containing bacteriophages
CN109561710A (en) * 2016-06-14 2019-04-02 普瑞特克微生物有限责任公司 Animal feed pellets comprising feed addictive, its preparation and application
RU2639544C1 (en) * 2016-12-16 2017-12-21 Общество с ограниченной ответственностью "БИОРЕАКТОР" Means for treatment and prevention of bird gastrointestinal tract diseases
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
CN107319103A (en) * 2017-08-01 2017-11-07 河南牧业经济学院 Promote feed addictive of growth of animals or poultry and intestinal growth and its preparation method and application
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
KR101939080B1 (en) * 2017-10-23 2019-01-16 고려대학교 산학협력단 Pseudomonas veronii strain KACC 81051BP and composition for comprising the same
CN109260235A (en) * 2018-10-23 2019-01-25 上海市第十人民医院 A kind of application of composition in preparation prevention and treatment constipation drug or health care product
CN110004072B (en) * 2018-11-12 2021-08-13 西安交通大学 Probiotic enterococcus faecalis isolate A3-1 and application thereof
CN113652340A (en) * 2021-08-24 2021-11-16 江苏江大源生态生物科技股份有限公司 Probiotic preparation, strain screening device and screening method
CN113616715B (en) * 2021-08-31 2022-05-06 昆明理工大学 Fermented traditional Chinese medicine oral liquid for treating piglet diarrhea and improving intestinal flora thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908028A (en) * 1973-04-19 1975-09-23 Procter & Gamble Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
CH675685A5 (en) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5082489A (en) * 1990-02-06 1992-01-21 The Royal Institution For The Advancement Of Learning (Mcgill University) Composition for biocontrol of wild buckwheat
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5486367A (en) * 1992-10-13 1996-01-23 Kansas State University Research Foundation Enzymatic method for accelerating fermentation of comestible products
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
AU714310B2 (en) * 1995-05-12 1999-12-23 Japan Pharmaceutical Development Co., Ltd Plant extract
EP0828502B1 (en) * 1995-05-26 2001-12-12 Ropapharm B.V. I.O. Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
GB2303799B (en) * 1995-07-29 1999-03-10 Siemens Plc Improvements in or relating to aqueous sample testing apparatus
US5888395A (en) * 1996-08-30 1999-03-30 The Regents Of The University Of California Method for enhanced longevity of in situ microbial filter used for bioremediation
US5773075A (en) * 1996-12-13 1998-06-30 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of Capsicum solids
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Also Published As

Publication number Publication date
EP1343370A4 (en) 2004-02-11
MXPA03004851A (en) 2004-05-04
CN1494374A (en) 2004-05-05
NZ526748A (en) 2006-03-31
AU2002221004B2 (en) 2007-01-25
WO2002043649A3 (en) 2002-08-29
RU2281326C2 (en) 2006-08-10
ZA200304747B (en) 2004-09-03
CA2430292A1 (en) 2002-06-06
WO2002043649A2 (en) 2002-06-06
PL366363A1 (en) 2005-01-24
IL156213A0 (en) 2003-12-23
EP1343370A2 (en) 2003-09-17
BR0116178A (en) 2003-10-14
JP2004534512A (en) 2004-11-18
KR20030082549A (en) 2003-10-22
CN1294253C (en) 2007-01-10
AU2100402A (en) 2002-06-11
JP4410992B2 (en) 2010-02-10

Similar Documents

Publication Publication Date Title
WO2002043649A3 (en) Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
HK1043154A1 (en) A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
WO2002082902A3 (en) A concentrated, water-soluble, granular plant growth regulator formulation and methods for use of same
WO1999001427A3 (en) Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
AU2002302642A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
MXPA03007427A (en) Coating compositions containing low voc compounds.
WO2001058412A3 (en) Extracts from residues left in the production of wine
AU2728900A (en) Multi-purpose acid compositions
WO2002041702A3 (en) Foods comprising a gel composition and process of manufacture
WO2002017885A3 (en) Controlled release formulation of erythromycin or a derivative thereof
HK1066174A1 (en) Lactic acid bacteria and/or bifidobacteria, a composition containing the same and the use thereof
MXPA02010982A (en) Fractionation and processing of oilseed meal.
PL355620A1 (en) Method for drying bacteria
WO2002004133A3 (en) Compositions for imparting desired properties to materials
WO2022079261A3 (en) Use of microorganisms and calcium for improved plant health and/or resilience against plant pathogens
MXPA04000106A (en) Aqueous compositions comprising a chemical microgel associated with an aqueous polymer.
Thanish Ahamed et al. Antibacterial activity of taxifolin isolated from acacia catechu leaf extract–An in vitro study
DK1331939T3 (en) Murraya koenigii extracts for the treatment of asthma
CA2400070A1 (en) Fast hydrating dispersible biopolymer
BR0102186A (en) Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders
CA2510933A1 (en) Methods of delivering materials into the skin, and compositions used therein
WO2002002115A3 (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals
WO2002100346A3 (en) (r, r'),(r',s')-amphetaminil, compositions and uses thereof
WO2002100342A3 (en) (s, s'), (s, r')-amphetaminil, compositions and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/004851

Country of ref document: MX

Ref document number: 156213

Country of ref document: IL

Ref document number: 2430292

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002545628

Country of ref document: JP

Ref document number: 1020037007337

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2003/04747

Country of ref document: ZA

Ref document number: 200304747

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2001998302

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 526748

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2003119151

Country of ref document: RU

Kind code of ref document: A

Ref country code: RU

Ref document number: RU A

WWE Wipo information: entry into national phase

Ref document number: 2002221004

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 018214851

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2001998302

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020037007337

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 10432346

Country of ref document: US

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 23/2002 DUE TO A TECHNICAL PROBLEMAT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING UNDER (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION

WWP Wipo information: published in national office

Ref document number: 526748

Country of ref document: NZ